Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02154490 |
|---|---|
| Brief Title: | Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer |
| First Submitted : | May 30, 2014 |
| First Submitted that Met QC Criteria : | June 2, 2014 |
| First Posted : | June 3, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | April 25, 2022 |
| Last Update Posted : | April 27, 2022 |